These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 16980084

  • 1. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G, Esposito L, Mengelle C, Kamar N, Ribes D, Lavayssière L, Pillet A, Suc B, Barange K, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV.
    Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience.
    Perrella A, Esposito C, Ioia G, Campanella L, Taglialatela D, Cuomo O.
    Transplant Proc; 2010 May; 42(4):1226-8. PubMed ID: 20534267
    [Abstract] [Full Text] [Related]

  • 5. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ, Alloway RR, Lo A, Hodge EE, PIVOT Study Group.
    Transplant Proc; 2004 May; 36(4):1082-3. PubMed ID: 15194376
    [Abstract] [Full Text] [Related]

  • 6. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.
    Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
    Boucher A, Lord H, Collette S, Morin M, Dandavino R.
    Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
    [Abstract] [Full Text] [Related]

  • 8. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
    Hoppe L, Marroni CA, Bressane R, Lago L, Schiavo FL, Cigerza GC, Brandão AB, Zanotelli ML, Cantisani GP.
    Transplant Proc; 2006 Dec; 38(6):1922-3. PubMed ID: 16908324
    [Abstract] [Full Text] [Related]

  • 9. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
    Pillet A, Mengelle C, Basse G, Ribes D, Kamar N, Muscari F, Lavayssière L, Suc B, Esposito L, Peron JM, Rostaing L.
    Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
    [Abstract] [Full Text] [Related]

  • 10. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
    Tryphonopoulos P, Weppler D, Morris MI, Russo C, Nishida S, Levi DM, Moon J, Tekin A, Selvaggi G, Island E, Arosemena L, Ruiz P, Tzakis AG.
    Transplantation; 2011 Nov 15; 92(9):1051-7. PubMed ID: 21876474
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gancyclovir prophylaxis in high risk patients.
    Campino A.
    Transplant Proc; 2005 Dec 15; 37(10):4311-2. PubMed ID: 16387106
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Müller AR, Steinmüller T, Neuhaus P.
    Liver Transpl; 2002 Dec 15; 8(12):1138-46. PubMed ID: 12474153
    [Abstract] [Full Text] [Related]

  • 15. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients.
    Hoppe L, Bressane R, Lago LS, Schiavo FL, Marroni CA, Keiserman DR, Brandão AB, Júnior AM, Cassal AP, Zanotelli ML, Cantisani GP.
    Transplant Proc; 2004 May 15; 36(4):961-3. PubMed ID: 15194334
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.
    Doyle AM, Warburton KM, Goral S, Blumberg E, Grossman RA, Bloom RD.
    Transplantation; 2006 Apr 27; 81(8):1106-11. PubMed ID: 16641594
    [Abstract] [Full Text] [Related]

  • 19. CMV, EBV, HHV6, and HHV7 infections after intestinal transplantation without specific antiviral prophylaxis.
    Pascher A, Klupp J, Schulz RJ, Dignass A, Neuhaus P.
    Transplant Proc; 2004 Mar 27; 36(2):381-2. PubMed ID: 15050166
    [Abstract] [Full Text] [Related]

  • 20. [Primary cytomegalovirus infection after combined cadaveric transplantation of the liver and kidney].
    Slavicek J, Puretić Z, Glavas-Boras S, Smalcelj R, Barisić I, Vuković J, Seso-Simić D, Slavicek V, Humar I, Kes P.
    Acta Med Croatica; 2003 Mar 27; 57(1):87-90. PubMed ID: 12876872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.